EMA – Public consultation on a multi-stakeholder platform to improve clinical trials in the EU
On 3 February 2023, EMA, the Heads of Medicines Agencies (HMA) and the European Commission (EC) are launching a public consultation on the establishment of a multi-stakeholder platform to improve clinical trials in the European Union (EU). The multi-stakeholder platform is a deliverable of the joint initiative Accelerating Clinical Trials in the EU (ACT EU).
Stakeholders are invited to send their comments on the ACT EU multi-stakeholder platform concept paper , advise on the key priorities for discussion and express their interest to join the platform via an online form until 3 March 2023 at midnight CET.
Read the news announcement on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (4 mai 2023). EMA – Public consultation on a multi-stakeholder platform to improve clinical trials in the EU. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o69i





